MacuScope release in new year

Click here to see a pdf of the article

Age-related macular degeneration (AMD) is the main cause of sight impairment in the UK.

There is much increasing excitement - reflected in these pages earlier this year - about the potential of some new treatment methods for certain presentations of the disease. It is, however, always worth remembering that the vast majority of AMD is of the untreatable atrophic variety.

Furthermore, it is clear that an increasing percentage of the eye care professional's patient base will include AMD as the main reason for attendance in clinics. Optical help and vision training, along with advice and community liaison, are all important in the long-term management strategy. But with no treatments immediately imminent, the importance of risk factors and how to minimise them is attracting more attention.